One of the areas that we've had the most precipitous decline in the last decade is the slowing of early-stage capital formation.

Too often, our regulatory system has become an impediment to innovation.

the President has identified a few areas that he has called for an 'all-hands-on-deck' approach to catalyze breakthroughs.

I personally believe not only should the R&E tax credit be made permanent, but it should be raised from 14 percent, hopefully up to 20 percent.

the rate of change that we'd seen across the 16 metrics that Dr. Atkinson will describe later.

It is long overdue. And I appreciate your interest in both competitiveness and innovation.

I think the greatest job and wealth creator in the next 25 years, worldwide, will be the energy sector.

I don't think our country's had much of an innovation or growth strategy for the last decade-plus.

Already, FDA's inconsistent approval process has dampened investment.

The longer it takes to get a new device to market, the less certainty investors have and the more capital businesses need.

The markets of tomorrow are not just going to be domestic, they're going to be all over the world.

The mission of NSF has basically morphed into one of supporting scientists at universities.

Minnesota, in my State, has led medical innovation for more than 60 years and boasts more than 400 medical device companies.

I believe tax policies ought to encourage long-term hold, early-stage capital formation.

We should expand the regular R&E tax credit.

It would help, since a third of that was tax cuts, and nobody in Virginia knew we gave them a tax cut, either.

I think it is a very big issue, this question of early-stage capital formation.

Changes to this process are always welcome. Safety should be the number-one focus.